272593 BUS 474 A 02/14/2011 Metabical After spending millions of dollars for ten years in research and development‚ Metabical was finally able to receive FDA approval‚ making it the first and only drug to receive FDA approval to meet the needs of customers who have been trying to lose weight. Like with any other new product‚ numerous issues need to be considered before Metabical is actually introduced in the market. Decisions about pricing‚ packaging and demand forecast of the product are key
Premium Obesity Pharmacology
• What is the decision making process for Metabical? ◦ Who is involved? ◦ What role do they play? ◦ What are the stages in the process? In the launch of Metabical for the US market‚ several marketing decisions need to be made to bring a viable product into the market to maximize market penetration and gross margins over the PLC and to best serve the needs of the customers The players are • Health Care Professionals ◦ Will prescribe Metabical to their patients ◦ Can influence Insurance Companies
Premium Marketing
Desventaja: por la independecia del nicho‚ el precio depende del comportamiento del consumidor. Aprovechar el posicionamiento de Metabical. Ventaja: buena valoración del producto Desventaja: ya que el mercado es bastante amplio‚ los consumidores podrían no pagar por el producto Compared to the competition: Advantage: fixed prices serve as a benchmark for pricing of metabical Disadvantage: The product would be similar to the competition for the consumer. Measure the own value: Advantage: It would
Premium Marketing Competition Market
Case Summary The Cambridge Sciences Pharmaceuticals (“CSP”) is an international healthcare company that had completed successful clinical trials for its newest weight loss prescription drug‚ Metabical. With the final FDA approval expected‚ Metabical’s launch was set for January 2009 and a clear marketing communications strategy needed to be in place before the launch. With 10 years and $400 million spent on research and development‚ it was imperative that CSP positions Metabical correctly in the
Premium Obesity Food and Drug Administration Health care
Case study : Metabical Positining and communication strategy for a new weight-loss drug Question 1 – How should Printup think about the segmentation of potential Metabical consumers? Who is the optimal target consumer? They should target women less than 65 especially (exhibit 2). They seem to be more aware than men to their weight. But most of the population (men and women) are now more conscious that losing weight is important for health. We can talk about normal customers including young
Premium Obesity Weight loss
Metabical is a prescription drug produced by Cambridge Sciences Pharmaceuticals (CSP) for weight loss‚ which was the first and only prescription drug to obtain FDA approval. The drug was developed to help aid people in the overweight segment to lose 10 to 30 pounds. Barbara Printup is the marketing director in charge of selecting a price for the new prescription drug. In a study CSP did with Metabical‚ people with a body mass index (BMI) of 28 to 30 had an average weight loss of 26 pounds over a
Premium Obesity Marketing
Case Study Metabical Introduction Cambridge Sciences Pharmaceuticals’ (CSP) is international health care company Focus on developing‚ manufacturing and marketing products that treat various deceases Want to enter the market for weight-control products in the US Sucessfully managed to develop Metabical‚ new revolutionary product for weight lost SWOT Analysis Strenghts First prescription drug Has Food and Drug Administration approval Good results in clinical trials and market
Premium
Metabical Case: Pricing‚ Packaging and Demand Forecasting Case Brief Demand Forecasting Packaging and Count Decision Pricing Strategy Introduction of new weight loss drugMetabical What is the expected demand? What are the factors deciding packaging count decisions? How many tablets in a packet of drug? What should be the pricing strategy? ROI Demand Forecastin g Case Brief Packaging and Count Decision Pricing Strategy ROI Demand Forecast: Option One Population Actively Overweight trying
Premium Supply and demand Pricing Household income in the United States
2) How should Printup think about the segmentation of potential Metabical consumers? Who is the optimal target consumer? The book of Marketing Management defines “Market Segmentation” as the process of dividing the market into group(s) of similar consumers and selecting the most appropriate to serve. Eventually‚ the selected group will be called the target market. According to this definition and the case on hand‚ Printup must decide on the parameters according to which she should start the segmentation
Premium Obesity Marketing Weight loss
Metabical Analysis 1) Benefits: * All other Weight-Loss Options in Exhibit 2 are more expensive that the target $30/ month out of pocket cost. * No other weight loss option offers cost containment cards. * No other product combines two mechanisms for weight loss: Metabical combines two pharmacologic mechanisms to produce weight loss: Fat blocker‚ meditonan and appetite suppressant‚ calosera. Due to the dual mechanism‚ the medications can be dosed in lower levels and therefore have
Premium Obesity Prescription drug Pharmacology